MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Progression of Motor & Non-motor symptoms of Parkinson’s Disease with Prior History of Head Trauma

    C. Kastoun, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Orange, USA)

    Objective: We compared the progression of motor (M) and nonmotor (NM) symptoms in subjects with Parkinson’s Disease (PD) with pre-existing head trauma (HT), with or…
  • 2025 International Congress

    Differentiated approach to treatment and diagnosis of Parkinson’s disease

    MRA. Abduvahabovna, ZUJ. Jahongir Qizi (Fergana, Uzbekistan)

    Objective: The anatomical and physiological characteristics of tremor in patients with Parkinson’s disease and essential tremor at the same age significantly influence diagnostic approaches, differentiation…
  • 2025 International Congress

    Resolution Dependence of Machine Learning for Differential Diagnosis of Parkinsonian Eye Movements

    O. Bredemeyer, S. Patel, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: To establish the extent to which high temporal resolution is required to differentiate between parkinsonian disease states from eye movements. Background: Previous studies have…
  • 2025 International Congress

    Multimodal and Agentic Simulated AI Patients for Bridging the gap in Parkinson Disease Education

    L. Okar, M. Fani (St. Louis, USA)

    Objective: To develop an AI training platform in PD counseling that utilizes real-time NLP processing, multimodal inputs/outputs, and adaptive reinforcement learning supported by immediate feedback…
  • 2025 International Congress

    Advancing Hypomimia Assessment in Parkinson’s Disease by Integrating a Continuous Monitoring Device into Clinical Practice

    A. Wiederhold, C. Gundler (Hamburg, Germany)

    Objective: We aim to establish a robust, continuous method for monitoring hypomimia in Parkinson’s disease (PD), bridging the gap between sporadic clinical evaluations and real-life…
  • 2025 International Congress

    Virtual Gait Lab: Assessment of Freezing of Gait in Parkinson’s Disease Using Virtual Reality

    K. Seo, M. Hara, S. Alaoui, S. Emoto, T. Ishii, K. Abe, G. Oyama, T. Yamamoto (Saitama, Japan)

    Objective: To develop and validate the effectiveness of a "Virtual Gait Lab" system using virtual reality (VR) technology for provoking and evaluating gait disturbances in…
  • 2025 International Congress

    Digital Measures for Clinical Trial Endpoints in Huntington’s Disease (MEND-HD): Study Design and Status Update

    J. Adams, J. Hausdorff, J. Mammen, P. Auinger, C. Dorney, S. Mahes, N. Shah, M. Tyo, M. Bjalme-Evans, L. Quinn (Rochester, USA)

    Objective: To evaluate and establish the analytical validation, reliability, and meaningfulness of digital measures of gait and chorea in early Huntington’s disease (HD). Background: HD…
  • 2025 International Congress

    Role of 7-Tesla MRI in assessing clinical symptoms in CSF1R-Related Disorders

    T. Chmiela, J. Dulski, A. Strongosky, E. Middlebrooks, Z. Wszolek (Katowice, Poland)

    Objective: To evaluate utility of 7-tesla magnetic resonance imaging (7T MRI) as a biomarker of CSR1R-Related Disorder (CSF1R-RD). Background: CSF1R-RD is a rapidly progressive neurodegenerative…
  • 2025 International Congress

    Whispers of Hope Motor and Psychiatric Recovery in Fahr’s Disease with High-Frequency rTMS: A Case Report

    D. Ortiz-Zacarias, JA. Sánchez Garza, S. Luna Garza, N. Gutierrez Canales, V. Medina Mier, S. Castillo-Torres, IE. Estrada-Bellman (Monterrey, Mexico)

    Objective: To present a case of FD showing significant motor and psychiatric improvement following high-frequency rTMS of the DLPFC Background: Fahr’s disease (FD) is a…
  • 2025 International Congress

    Diagnostic mismatches between clinical assessment, imaging and alpha-synuclein biomarkers in parkinsonian syndromes

    A. Gomez, C. Malatt, E. Hogg, E. Tan, Y. Bordelon, B. Frommel, M. Tagliati (Los Angeles, USA)

    Objective: To analyze the frequency of matching information provided by traditional clinical assessment, dopamine transporter (DaTscan), and skin biopsy results in patients with undiagnosed parkinsonian syndromes. Background:…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley